Wanjun Wang, Qiurong Hu, Yanqing Xie, Mo Xian, Nili Wei, Jing Li
1 Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
2 Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.
Am J Rhinol Allergy. 2018 Jul;32(4):236-243. doi: 10.1177/1945892418779435. Epub 2018 Jun 17.
Background The results of skin and blood allergen testing are not consistently relevant to clinical manifestations in allergic patients. Objective The aim of the study was to investigate the relationship between severity of allergic rhinitis and different allergen diagnostic tests in Dermatophagoides species-sensitized patients. Methods Study subjects included 65 rhinitis patients-50 with Dermatophagoides pteronyssinus (DP) sensitization (DP+) and 15 without DP sensitization (DP-), and 15 DP+ and 37 DP- healthy controls (HCs) confirmed by allergen skin prick (SPT) and blood specific immunoglobulin E (sIgE) tests. The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was tested. All subjects underwent DP nasal provocation test (DP-NPT). Visual analogue scoring (VAS) of nasal symptoms and nasal airway resistance (NAR) were measured before and after NPT. Correlations between the 3 allergen tests and score of RQLQ were performed. Results All rhinitis subjects had significantly higher VAS and NAR after DP-NPT than HCs ( P < .01). All DP+ rhinitis, 40% of DP- rhinitis subjects, 13.3% of DP+ HCs and 0% of DP- HCs had positive DP-NPT. Dose of positive DP-NPT positively correlated with SPT diameter and sIgE level in all tested subjects ( P < .001). Score of RQLQ positively correlated with dose of DP-NPT ( P < .001), but not with SPT diameter and sIgE level in rhinitis patients. Conclusion Although DP nasal provocation, skin prick wheal size and blood sIgE level correlate with each other, only nasal provocation testing is associated with severity of nasal symptoms. It is suggested that NPT should be performed to verify a clinically relevant allergy.
皮肤和血液过敏原检测结果与过敏患者的临床表现并非始终相关。
本研究旨在调查尘螨致敏患者中过敏性鼻炎的严重程度与不同过敏原诊断测试之间的关系。
研究对象包括65例鼻炎患者——50例对屋尘螨(DP)致敏(DP+)和15例未对DP致敏(DP-),以及15例DP+和37例DP-健康对照(HCs),通过过敏原皮肤点刺试验(SPT)和血液特异性免疫球蛋白E(sIgE)检测确诊。对鼻结膜炎生活质量问卷(RQLQ)进行测试。所有受试者均接受DP鼻激发试验(DP-NPT)。在NPT前后测量鼻症状的视觉模拟评分(VAS)和鼻气道阻力(NAR)。对三种过敏原检测与RQLQ评分之间进行相关性分析。
所有鼻炎受试者在DP-NPT后VAS和NAR均显著高于HCs(P < 0.01)。所有DP+鼻炎患者、40%的DP-鼻炎患者、13.3%的DP+ HCs和0%的DP- HCs的DP-NPT呈阳性。在所有受试对象中,阳性DP-NPT的剂量与SPT直径和sIgE水平呈正相关(P < 0.001)。RQLQ评分与DP-NPT的剂量呈正相关(P < 0.001),但在鼻炎患者中与SPT直径和sIgE水平无关。
虽然DP鼻激发试验、皮肤点刺风团大小和血液sIgE水平相互关联,但只有鼻激发试验与鼻症状的严重程度相关。建议进行NPT以验证临床相关的过敏反应。